Massachusetts Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Buy
13,203
+325
+3% +$29K 0.49% 70
2025
Q4
$1.02M Buy
12,878
+106
+0.8% +$8.31K 0.47% 71
2025
Q3
$1.02M Sell
12,772
-50
-0.4% -$4.26K 0.51% 71
2025
Q2
$1.17M Buy
12,822
+225
+2% +$20.5K 0.66% 61
2025
Q1
$1.18M Sell
12,597
-250
-2% -$22.4K 0.81% 49
2024
Q4
$1.17M Sell
12,847
-500
-4% -$47.7K 0.72% 59
2024
Q3
$1.39M Sell
13,347
-75
-0.6% -$7.64K 0.87% 51
2024
Q2
$1.3M Sell
13,422
-100
-0.7% -$9.22K 0.87% 47
2024
Q1
$1.22M Buy
13,522
+350
+3% +$29.7K 0.86% 51
2023
Q4
$1.05M Buy
13,172
+9
+0.1% +$677 0.85% 50
2023
Q3
$936K Sell
13,163
-50
-0.4% -$3.74K 0.86% 48
2023
Q2
$1.02M Sell
13,213
-100
-0.8% -$7.74K 0.97% 44
2023
Q1
$1M Sell
13,313
-200
-1% -$14.9K 1.03% 41
2022
Q4
$1.01M Buy
+13,513
New +$1.01M 0.97% 44

Other funds holding CL

Massachusetts Wealth Management's CL Position: Q1 2026 in Review

Massachusetts Wealth Management increased its Colgate-Palmolive (CL) stake by 2.5% in Q1 2026, buying an estimated $29K and bringing the position to 13,203 shares worth $1.13M. The position accounts for 0.49% of the portfolio, ranked #70.

Massachusetts Wealth Management first reported a position in CL in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.39M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Massachusetts Wealth Management held 13,203 shares of Colgate-Palmolive worth $1.13M as of Q1 2026.
  • Massachusetts Wealth Management bought 325 Colgate-Palmolive shares in Q1 2026, an estimated $29K.
  • Colgate-Palmolive made up 0.49% of Massachusetts Wealth Management's portfolio in Q1 2026, its #70 holding.
  • Massachusetts Wealth Management first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 14 quarters since.
  • Massachusetts Wealth Management's Colgate-Palmolive position peaked at $1.39M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Massachusetts Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.